Battle gets fiercer over antihypertensive market

Large pharmaceutical firms have waged fiercer campaigns to raise their Cozaar (losartan) generic market share amid forecasts that their revenues will fall gradually due to stronger competition from other 30 drugmakers

Major pharmaceutical companies, such as Dong-A and Yuhan Corp., have started aggressive marketing in a bid to develop new cash cows amid the negative view for undue rebate prov...